Replication-competent Herpes simplex virus mediates destruction

Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A01N 6300, A61K 4800

Patent

active

061398349

ABSTRACT:
A method for killing malignant brain tumor cells in vivo entails providing replication competent herpes simplex virus vectors to tumor cells. A replication competent herpes simplex virus vector, with defective expression of the .gamma.34.5 gene and the ribonucleotide reductase gene, specifically destroys tumor cells, is hypersensitive to anti-viral agents, and yet is not neurovirulent.

REFERENCES:
patent: 5728379 (1998-03-01), Martuza et al.
XO Breakefield et al. New Biologist 3:203-218, 1991.
Toda, et al. "Treatment of Human Breast Cancer in a Brain Metastatic Model by G207, a Replication-Competent Multimutated Herpes simplexVirus 1", Human Gene Therapy 9:2177-2185 (Oct. 1998).
Chahlavi, et al. "Replication-Competent Herpes simplexVirus Vector G207 and Cisplatin Combination Theapy for Head and Neck Squamous Cell Carcinoma", Neoplasia 1(2):162-169 (Jun. 2, 1999).
Toda, et al. "Herpes simplexVirus as an in Situ Cancer Vaccine for the Induction of Spectrum Anti-Tumor Immunity", Human Gene Therapy 10:385-393 (Feb. 10, 1999).
Nilaver, et al. "Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption", Proc. Natl. Acad. Sci. USA 92:9829-9833 (Oct. 1995).
Neuwelt et al. "Delivery of ultraviolet-inactivated .sup.35 S-herpesvirus across an osmotically modified blood-brain barrier", J. Neurosurg 74:475-479 (Mar. 1991).
Walker, et al. "Local and systemic therapy of human prostate adenocarcinoma with the conditionally replicating Herpes simplexvirus vector G207", Human Gene Therapy, pp. 1-28 (In Press Sep. 1999).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Replication-competent Herpes simplex virus mediates destruction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Replication-competent Herpes simplex virus mediates destruction , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replication-competent Herpes simplex virus mediates destruction will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2047969

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.